Cognitive Dysfunction
337
78
99
140
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
28 trials with published results (8%)
Research Maturity
140 completed trials (42% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.7%
9 terminated out of 337 trials
94.0%
+7.4% vs benchmark
4%
15 trials in Phase 3/4
20%
28 of 140 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 140 completed trials
Clinical Trials (337)
Determination of the Effect of Puzzle Use in Elderly Patients
COMPuter-assisted Self-training to Improve EXecutive Function
Sleep Architecture, Cognitive Function, and Quality of Life During Early Recovery From Substance Use Disorder
A Study of Retinal Imaging to Detect Abnormal Protein Deposits Associated With Alzheimer's Disease
taVNS + CCT for Neurocognitive Rehab
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
COG+OT Telerehabilitation for Adults With Subjective Cognitive Complaints
Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers
Probiotic Impact on Cognitive Performance, and Metabolic Outcomes in Overweight Young Adults With Impaired Glucose Regulation
Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use
HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH)-Parkinson's Disease (HOBSCOTCH-Parkinson's)
Longevity Metrics AI/ML Development Study
Human Observatory Study
Health Ahead Comparative Effectiveness Study
100-Year Human Aging Study
Immersive Nature-Based Wellbeing Program in Older Adults With Cognitive Impairment
ToolBox Detect: Low Cost Detection of Cognitive Decline in Primary Care Settings
PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing
Efficacy of Gamma Auditory Stimulation for Cognitive Decline in Older Adults (Study 1)
Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy